Related Experiment Video

Updated: Apr 28, 2026

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
04:56

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients

Published on: August 4, 2023

1.4K

Dispelling myths about coagulation abnormalities in internal medicine

Jecko Thachil1

  • 1Department of Haematology, Manchester Royal Infirmary, Manchester, UK jecko.thachil@cmft.nhs.uk.

Clinical Medicine (London, England)
|June 4, 2014
PubMed

Insights

Routine clotting screens are vital blood tests, but abnormal results for prothrombin time and activated partial thromboplastin time are often missed. Understanding the coagulation system is key to interpreting these results and avoiding misconceptions in patient management.

Area of Science:

  • Hematology
  • Clinical Pathology
  • Medical Diagnostics

Background:

  • Clotting screens are integral to routine medical ward blood tests.
  • Abnormal results for prothrombin time (PT) and activated partial thromboplastin time (aPTT) may be overlooked.
  • Accurate interpretation necessitates a strong grasp of the coagulation cascade and laboratory analysis.

Purpose of the Study:

  • To address misconceptions surrounding abnormal clotting screen results.
  • To clarify the clinical implications of coagulation test abnormalities.
  • To provide guidance on appropriate patient management strategies.

Main Methods:

  • Review of common misconceptions regarding clotting screens.
  • Discussion of the coagulation system's complexities.
  • Analysis of clinical scenarios with abnormal coagulation parameters.

Main Results:

  • Identified prevalent misunderstandings in interpreting PT and aPTT.
  • Highlighted the gap between laboratory findings and expected clinical effects.
  • Emphasized the need for improved understanding among healthcare professionals.

Conclusions:

  • Enhanced understanding of coagulation is crucial for accurate interpretation of clotting screens.
  • Addressing misconceptions can lead to more appropriate clinical decision-making.
  • Proper management of patients with abnormal clotting tests requires a solid foundation in hematology.

Keywords:
Coagulationplasmaprothrombin timethromboplastin time

More Related Videos

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time09:38

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

16.3K
The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well06:59

The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

Published on: February 27, 2026

165

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.4K
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.8K